# Assessing Suzetrigine for Pain Reduction Following Ureteroscopic Surgery

> **NCT07654296** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Opioid Consumption, Postoperative
- Multimodal Analgesia
- Ureteroscopy
- Ureteral Stents
- Ureteral Stent-Related Symptoms

## Interventions

- **DRUG:** multimodal analgesia regimen without suzetrigine
- **DRUG:** Suzetrigine

## Key facts

- **NCT ID:** NCT07654296
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07654296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07654296, "Assessing Suzetrigine for Pain Reduction Following Ureteroscopic Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07654296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*